Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer. ( vol 16, 3885 , 2024)

被引：0
|
作者：
Dekker, Simone E. [1 ,2 ]
Deng, Lei [1 ,2 ]
机构：
[1] UNIV WASHINGTON, Sch Med, Dept Med, Div Hematol & Oncol, SEATTLE, WA 98195 USA
[2] Fred Hutchinson Canc Ctr, Clin Res Div, Seattle, WA 98109 USA
来源：
CANCERS | 2025年 / 17卷 / 01期
关键词：
D O I：
10.3390/cancers17010098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer
    Hanfei Guo
    Wenqian Li
    Lei Qian
    Jiuwei Cui
    Chinese Journal of Cancer Research, 2021, 33 (02) : 203 - 215
  • [42] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Bircan, Sema
    Baloglu, Huseyin
    Kucukodaci, Zafer
    Bircan, Ahmet
    MEDICAL ONCOLOGY, 2014, 31 (08)
  • [43] THE IMPACT OF KRAS MUTATIONS ON THE TUMOUR MICROENVIRONMENT AND TREATMENT RESPONSE IN NON-SMALL CELL LUNG CANCER
    Gu, Guomin
    Liu, Chunling
    Yang, Yan
    Zhao, Yan
    Zhu, Xiaodan
    Sun, Gang
    POLISH JOURNAL OF PATHOLOGY, 2024, 75 (04) : 353 - 361
  • [44] A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations
    Lei, Lei
    Wang, Wen-xian
    Yu, Zong-yang
    Liang, Xian-bin
    Pan, Wei-wei
    Chen, Hua-fei
    Wang, Li-ping
    Fang, Yong
    Wang, Min
    Xu, Chun-wei
    Fang, Mei-yu
    TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 329 - 335
  • [45] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Sema Bircan
    Huseyin Baloglu
    Zafer Kucukodaci
    Ahmet Bircan
    Medical Oncology, 2014, 31
  • [46] Cytological samples for the study of EGFR, KRAS and ALK mutations in non-small cell lung cancer
    Becker, Caroline
    Carcereny Costa, Enric
    Andreo Garcia, Felipe
    Castella, Eva
    Lletjos Sanuy, Mariona
    Moran, Teresa
    Mijangos Basterra, Erika
    Sanz Santos, Jose
    Centeno Clemente, Carmen
    Ruiz Manzano, Juan
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [47] Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer
    Saber, Ali
    van der Wekken, Anthonie J.
    Kerner, Gerald S. M. A.
    van den Berge, Maarten
    Timens, Wim
    Schuuring, Ed
    ter Elst, Arja
    van den Berg, Anke
    Hiltermann, T. Jeroen N.
    Groen, Harry J. M.
    PLOS ONE, 2016, 11 (03):
  • [48] Implications of KRAS Mutations on Outcomes in Non-small Cell Lung Cancer Treated With Radiation Therapy
    Welsh, J. W.
    Likacheva, A.
    Byers, L. A.
    Bhardwaj, V.
    Diao, L.
    Wang, J.
    Ang, K.
    Komaki, R.
    Kim, E.
    Heymach, J. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S70 - S70
  • [49] Identification of a New Potent Inhibitor Targeting KRAS in Non-small Cell Lung Cancer Cells
    Xie, Chun
    Li, Ying
    Li, Lan-Lan
    Fan, Xing-Xing
    Wang, Yu-Wei
    Wei, Chun-Li
    Liu, Liang
    Leung, Elaine Lai-Han
    Yao, Xiao-Jun
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [50] Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications
    Ricciuti, Biagio
    Leonardi, Giulia Costanza
    Metro, Giulio
    Grignani, Francesco
    Paglialunga, Luca
    Bellezza, Guido
    Baglivo, Sara
    Mencaroni, Clelia
    Baldi, Alice
    Zicari, Daniela
    Crino, Lucio
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (01) : 53 - 68
12345